0.68
전일 마감가:
$0.685
열려 있는:
$0.66
하루 거래량:
37,388
Relative Volume:
0.60
시가총액:
$19.46M
수익:
$38.25M
순이익/손실:
$-17.87M
주가수익비율:
-1.1148
EPS:
-0.61
순현금흐름:
$4.33M
1주 성능:
-3.06%
1개월 성능:
-15.53%
6개월 성능:
-9.45%
1년 성능:
-39.82%
Retractable Technologies Inc Stock (RVP) Company Profile
명칭
Retractable Technologies Inc
전화
972-294-1010
주소
511 Lobo Lane, Little Elm, TX
RVP을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
RVP
Retractable Technologies Inc
|
0.68 | 19.46M | 38.25M | -17.87M | 4.33M | -0.61 |
![]()
ISRG
Intuitive Surgical Inc
|
451.58 | 166.19B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
207.34 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
83.82 | 42.07B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
205.17 | 30.34B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
WST
West Pharmaceutical Services Inc
|
203.21 | 15.34B | 2.88B | 499.60M | 321.60M | 6.74 |
Retractable Technologies Inc 주식(RVP)의 최신 뉴스
Retractable Technologies CEO Thomas Shaw buys $1,046 in stock - Investing.com
Retractable Technologies CEO Thomas Shaw buys $1,046 in stock By Investing.com - Investing.com UK
Retractable Technologies CEO Thomas Shaw acquires shares worth $16,760 - Investing.com
Retractable technologies CEO Thomas Shaw buys $4,969 in stock By Investing.com - Investing.com Philippines
Retractable Technologies Faces Critical Year: Revenue Plunges as Cash Drops to $4.2M - Stock Titan
Retractable Technologies, Inc. Reports Results for 2024 - Joplin Globe
Medical Safety Leader Retractable Technologies Maintains Strong Dividend Program - Stock Titan
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders - Bluefield Daily Telegraph
Retractable Technologies Inc. (RVP) reports earnings - Quartz
Retractable technologies CEO Thomas Shaw buys $4,969 in stock - Investing.com
StockNews.com Begins Coverage on Retractable Technologies (NYSE:RVP) - Defense World
Retractable Technologies CEO Thomas Shaw acquires shares worth $717 By Investing.com - Investing.com Australia
Retractable Technologies CEO Thomas Shaw acquires shares worth $717 - Investing.com
Tuesday’s Top Insider Trades: Notable Buys and Sells Revealed By Investing.com - Investing.com Philippines
Disposable Syringes Market Projected To Witness Substantial - openPR.com
Retractable Technologies CEO Thomas Shaw buys $542 in stock By Investing.com - Investing.com South Africa
Retractable Technologies CEO Thomas Shaw buys $542 in stock - Investing.com
Disposable Syringes Market Forecast: 6.1% CAGR to Drive Growth to US$ 17,026.2 Million by 2035 – Analysis by TMR - PharmiWeb.com
Retractable Technologies CEO Thomas Shaw buys $22,774 in stock - MSN
U.S. Safety Needles Market Growth in Future Scope 2025-2032 | - openPR.com
StockNews.com Initiates Coverage on Retractable Technologies (NYSE:RVP) - The AM Reporter
Retractable Technologies (NYSE:RVP) Now Covered by StockNews.com - Defense World
Blood Collection Market Size Projected to Hit USD 7.25 - GlobeNewswire
Key Trend Shaping the High Flow Needle Sets Market in 2025: Development Of Portable Syringe Infusion System... - WhaTech
Smart Syringe Pumps Market: Revolutionizing Precision - openPR
Global Disposable Syringes Market 2034: Industry Scope, Size & Future Trends - PharmiWeb.com
Hypodermic Syringes And Needles Market Redefining Connectivity and Efficiency in the Digital Era - ExpressVartha
Hypodermic Needles Market growing at a CAGR of 3.4% from 2020 to 2030 - EIN News
Peripheral Intravenous Catheters Market Detailed In New - openPR
Medical Hypodermic Syringe Market Unlocking Growth Opportunities Through Smart Solutions - ExpressVartha
Retractable Needle Safety Syringes Market Enabling Agile and Scalable Business Models in the Digital Age - ExpressVartha
Disposable Syringes Market Future Business Opportunities - openPR
Retractable Technologies (NYSE:RVP) Now Covered by Analysts at StockNews.com - Defense World
Retractable Technologies CEO Thomas Shaw buys $42,658 in common stock - Investing.com India
Retractable Technologies CEO Thomas Shaw buys $42,658 in common stock By Investing.com - Investing.com Australia
Disposable Syringes Market Set for Robust Growth, Reaching - GlobeNewswire
Smart Syringe Market To Witness Huge Growth By 2035 In The Latest Report - WhaTech
Retractable technologies CEO Thomas Shaw buys $14,974 in common stock By Investing.com - Investing.com Australia
Retractable technologies CEO Thomas Shaw buys $14,974 in common stock - Investing.com India
Syringes Market to reach $32,394.74 Million by 2027, registering a CAGR of 9.6 % - EIN News
Retractable Technologies (NYSE:RVP) Coverage Initiated by Analysts at StockNews.com - Defense World
Global Automated Blood Collection Market Forecast 2025-2034: Analyzing Growth Drivers, Share, Segments, And - EIN News
Retractable Needle Safety Syringes Market to Grow at 5.9% CAGR - EIN News
Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com - Defense World
Comparing Retractable Technologies (NYSE:RVP) and Boston Scientific (NYSE:BSX) - Defense World
Retractable Technologies CEO Thomas Shaw acquires $14,082 in stock By Investing.com - Investing.com Australia
Retractable Technologies CEO Thomas Shaw acquires $14,082 in stock - MSN
Retractable Technologies Inc (RVP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):